| Industry | 制造业 | ||||||||||||||||||||||||
| Company Introduction | 江苏硕世生物科技股份有限公司创立于2010年，坐落于中国首家国家级医药高新区——江苏泰州中国医药城，2019年12月5日在上海证券交易所科创板上市，股票代码688399。硕世生物以分子诊断技术为核心，是集诊断试剂、仪器、第三方医学检验服务为一体的整体解决方案的国家高新技术企业，目前已成为国内分子诊断行业的标杆企业。 使命：硕世诊断 为健康 愿景：努力在全球诊断试剂行业占有一席之地 核心价值观：品质、效率、公平、公正 研发能力雄厚 多种设备支持，产品获得专业认证 公司建有核酸及蛋白质两个符合国家医疗器械生产质量管理规范的洁净生产车间，并通过了ISO13485质量体系认证；拥有科技部“创新创业”人才、江苏省“双创团队”荣誉称号，被国家人力资源和社会保障部评选为2013年度“最具成长潜力的留学人员创业企业”。 产品方面，公司拥有多重荧光定量PCR、酶化学等多个现代生物学技术平台，从事疾病预防控制、女性生殖道微生态检测及肿瘤筛查等领域的产品研发、生产及销售。成功开发出传染病病原体检测、女性生殖道微生态检测、肿瘤筛查等近500个产品，多个产品已经获得药监局颁发的Ⅲ类或Ⅱ类产品注册证。 人才企业之本 高素质人才是公司的重要资产 在疾病预防控制领域，公司是疾控核酸类检测产品重要的供应商，在2013年的H7N9禽流感病毒、2014年西非爆发埃博拉病毒以及2020年爆发的新型冠状病毒肺炎的防控工作中，均做出非常重要的贡献。在临床检验领域，公司是女性下生殖道微生态检测产品的重要供货商。 未来，公司将持续秉承“硕世诊断，为健康”的使命，并以“品质、效率、公平、公正”的企业文化为指导，为客户提供好的产品和完善的服务。 | ||||||||||||||||||||||||
| Main Business | 体外诊断试剂、配套检测仪器等体外诊断产品的研发、生产和销售，并拓展到体外检测服务领域，实现“仪器+试剂+服务”的一体化经营模式。 | ||||||||||||||||||||||||
| Legal Representative | 王国强 | ||||||||||||||||||||||||
| Top Executives |
|
||||||||||||||||||||||||
| Top 5 Shareholder |
|
||||||||||||||||||||||||
| Company Secretary | 胡园园 | ||||||||||||||||||||||||
| Solicitors | 上海市通力律师事务所 | ||||||||||||||||||||||||
| Auditors | 立信会计师事务所（特殊普通合伙） | ||||||||||||||||||||||||
| Tel No | 0523-80225599 | ||||||||||||||||||||||||
| Fax No | 0523-86201617 | ||||||||||||||||||||||||
| Website | www.s-sbio.com | ||||||||||||||||||||||||
| sssw@s-sbio.com | |||||||||||||||||||||||||
| Company Address |
|
||||||||||||||||||||||||
| Listing Date | 05/12/2019 | ||||||||||||||||||||||||
| Shares Capital |
|
||||||||||||||||||||||||
| EPS(RMB)* | ¥ -6.380 | ||||||||||||||||||||||||
| DPS(RMB)* | -- | ||||||||||||||||||||||||
| NBV Per Share(RMB)* | ¥ 58.088 | ||||||||||||||||||||||||
| Market Capitalization(RMB) | 3.906B |
 |
Only Chinese content is avaliable |
|
N
/
N
: Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SH-HK Ex-Northbound trade (sell only)
|
|
|
N
/
N
: Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
: Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
|
|
| * | Unadjusted Data |
| Information provided by: etnet | ||
| Terms and Conditions | ||
| Risk Disclosure: |
| The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone. |
| Disclaimer: |
| This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information. |